Non-nucleoside inhibitors of the hepatitis C virus NS5B RNA-dependant RNA polymerase: 2-Aryl-3-heteroaryl-1,3-thiazolidin-4-one derivatives

Bioorganic and Medicinal Chemistry Letters

Volumn 18, Issue 23, 2008, Pages 6110-6114

  Rawal, Ravindra K ^a   Katti, S B ^a   Kaushik Basu, Neerja ^b   Arora, Payal ^b   Pan, Zhenhua ^b  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

4 Thiazolidinones; HCV; NS5B; RdRp

Indexed keywords

1,3 THIAZOLIDIN 4 ONE DERIVATIVE; ANTIVIRUS AGENT; RNA DIRECTED RNA POLYMERASE; RNA DIRECTED RNA POLYMERASE INHIBITOR; THIAZOLIDINE DERIVATIVE; UNCLASSIFIED DRUG; WEDELOLACTONE;

ANTIVIRAL ACTIVITY; ARTICLE; DRUG SYNTHESIS; HEPATITIS C VIRUS; IC 50; NONHUMAN; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION; VIRUS INHIBITION;

ANTIVIRAL AGENTS; COMBINATORIAL CHEMISTRY TECHNIQUES; DRUG DESIGN; HEPACIVIRUS; HEPATITIS C; INHIBITORY CONCENTRATION 50; MOLECULAR STRUCTURE; RNA REPLICASE; STRUCTURE-ACTIVITY RELATIONSHIP; THIAZOLIDINES; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 55549132596     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2008.10.023     Document Type: Article

References (44)

1. Choo Q.-L., Han J., Weiner A.J., Overby L.R., Bradley D.W., Kuo G., and Houghton M. Hepatitis C Virus is a Distant Relative of the Flaviviruses and Pestiviruses. In: Shikata T., Purcell R.H., and Uchida T. (Eds). Viral Hepatitis C, D and E (1991), Elsevier Science Publishers B.V., Amsterdam, The Netherlands 47-52
2. Choo Q.-L., Richman K.H., Han J.H., Berger K., Lee C., Dong C., Gallegos C., Coit D., Medina-Selby A., Barr P.J., Weiner A.J., Bradley D.W., Kuo G., and Houghton M. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 2451
3. McHutchison J.G. Am. J. Manag. Care 10 (2004) S21
4. Cohen J. Science 285 (1999) 26
5. Reed K.E., and Rice C.M. Curr. Top. Microbiol. Immunol. 242 (2000) 55
6. Beaulieu P.L., and Montse L.-B. Curr. Med. Chem.: Anti-Infect. Agents 1 (2002) 163
7. Gordon C.P., and Keller P.A. J. Med. Chem. 48 (2005) 1
8. De Francesco R., and Migliaccio G. Nature 436 (2005) 953
9. Wu J.Z., and Hong Z. Curr. Drug Targets: Infect. Disord. 3 (2003) 207
10. LaPlante S., Jakalian A., Aubry N., Bousquet Y., Ferland J.-M., Gillard J., Lefebvre S., Poirier M., Tsantrizos Y.S., Kukolj G., and Beaulieu P.L. Angew. Chem. Int. Ed. 43 (2004) 4306
11. Tan S.-L., He Y., Huang Y., and Gale Jr. M. Curr. Opin. Pharmacol. 4 (2004) 465
12. Beaulieu P.L., and Tsantrizos Y.S. Curr. Opin. Investig. Drugs 5 (2004) 838
13. Gordon C.P., and Keller P.A. J. Med. Chem. 48 (2005) 1
14. Condon S.M., LaPorte M.G., and Herbertz T. Curr. Med. Chem.: Anti-Infect. Agents 4 (2005) 99
15. De Francesco R., and Migliaccio G. Nature 436 (2005) 953
16. Beaulieu P.L., Bousquet Y., Gauthier J., Gillard J., Marquis M., McKercher G., Pellerin C., Valois S., and Kukolj G. J. Med. Chem. 47 (2004) 6884
17. Harper S., Avolio S., Pacini B., Di Filippo M., Altamura S., Tomei L., Paonessa G., Di Marco S., Carfi A., Giuliano C., Padron J., Bonelli F., Migliaccio G., De Francesco R., Laufer R., Rowley M., and Narjes F. J. Med. Chem. 48 (2005) 4547
18. Tedesco R., Shaw A.N., Bambal R., Chai D., Concha N.O., Darcy M.G., Dhanak D., Fitch D.M., Gates A., Gerhardt W.G., Halegoua D.L., Han C., Hofmann G.A., Johnston V.K., Kaura A.C., Liu N., Keenan R.M., Lin-Goerke J., Sarisky R.T., Wiggall K.J., Zimmerman M.N., and Duffy K.J. J. Med. Chem. 49 (2006) 971
19. Hirashima S., Suzuki T., Ishida T., Noji S., Yata S., Ando I., Komatsu M., Ikeda S., and Hashimoto H. J. Med. Chem. 49 (2006) 4721
20. Afdhal, N.; Rodriguez-Torres, M.; Lawitz, E.; Godofsky, E.; Chao, G.; Fielman, B.; Knox, S.; Broen, N. 40th EASL, Enhanced Antiviral Efficacy for Valopicitabine (NM283) plus Peg-interferon in Hepatitis C Patients with HCV Genotype-1 Infection: Results of a Phase IIa Multicenter Trial, Paris, France, April 13-17, 2005.
21. Roberts, S.; Cooksley, G.; Shaw, D.; Berns, H. K.; Brandl, M. T.; Fettner, S. H.; Hill, G.; Ipe, D.; Klumpp, K.; Mannino, M.; O'Mara, E.; Tu, Y.; Washington, C. B. Abstract 731, 41st EASL, Interim Results of a Multiple Ascending Dose Study of R1626, A Novel Nucleoside Analog Targeting HCV Polymerase in Chronic HCV Patients, Vienna, Austria.
22. Chandra, C.; Raible, D.; Harper, D.; Speth, J.; Villano, S.; Bichier, G. DDW 2006, Antiviral Activity of the Non-nucleoside Polymerase Inhibitor, HCV-796. In Patients with Chronic Hepatitis C Virus: Preliminary Results from a Randomized, Double-blind, Placebo-controlled, Ascending Multiple Dose Study, Los Angeles, CA, May 20-25, 2006.
23. Kaushik-Basu N., Bopda-Waffo A., Talele T.T., Basu A., Costa P.R., Da Silva A.J., Sarafianos S.G., and Noël F. Nucleic Acids Res. 365 (2008) 1482
24. Anders C.J., Bronson J.J., D'Andrea S.V., Deshpande S.M., Falk P.J., Grant-Young K.A., Harte W.E., Ho H., Misco P.F., Robertson J.G., Stock D., Sun Y., and Walsh A.W. Bioorg. Med. Chem. Lett. 10 (2000) 715
25. Kucukguzel S.G., Oruc E.E., Rollas S., Sahin F., and Ozbek A. Eur. J. Med. Chem. 37 (2002) 197
26. Karali N., Ilhan E., Gürsoy A., and Kiraz M. Farmaco 53 (1998) 346
27. Fahmy H.T.Y. Boll. Chim. Farm. 140 (2001) 422
28. Ergenc N., and Capan G. Farmaco 49 (1994) 133
29. Capan G., Ergenc N., Ekinci A.C., and Vidin A. Farmaco 51 (1996) 729
30. Look G.C., Schullek J.R., Homes C.P., Chinn J.P., Gordon E.M., and Gallop M.A. Bioorg. Med. Chem. Lett. 6 (1996) 707
31. Bukowski L., Janowiec M., Zwolska-Kwiek Z., and Andrezejczyk Z. Pharmazie 53 (1998) 373
32. Ulusoy N. Arzneim.-Forsch. Drug Res. 52 (2002) 565
33. Babaoglu K., Page M.A., Jones V.C., McNeil M.R., Dong C., Naismith J.H., and Lee R.E. Bioorg. Med. Chem. Lett. 13 (2003) 3227
34. Diurno M.V., Mazzoni O., Calignano P.E., Giordano F., and Bolognese A. J. Med. Chem. 35 (1992) 2910
35. Bhatt J.J., Shah B.R., Shah H.P., Trivedi P.B., Undavia N.K., and Desai N.C. Indian J. Chem. 33B (1994) 189
36. Barreca M.L., Balzarini J., Chimirri A., De Clercq E., Luca L.D., Holtje M.H., Holtje M., Monforte A.M., Monforte P., Pannecouque C., Rao A., and Zappala M. J. Med. Chem. 45 (2002) 5410
37. Rawal R.K., Prabhakar Y.S., Katti S.B., and De Clercq E. Bioorg. Med. Chem. 13 (2005) 6771
38. Rawal R.K., RajaSolomon V., Prabhakar Y.S., Katti S.B., and De Clercq E. Comb. Chem. High Throughput Screening 8 (2005) 439
39. Rawal R.K., Tripathi R., Katti S.B., Pannecouque C., and De Clercq E. Bioorg. Med. Chem. 15 (2007) 1725
40. Rawal R.K., Tripathi R., Katti S.B., Pannecouque C., and De Clercq E. Bioorg. Med. Chem. 15 (2007) 3134
41. Rawal R.K., Tripathi R., Katti S.B., Pannecouque C., and De Clercq E. Med. Chem. 3 (2007) 355
42. Barreca M.L., Chimirri A., Luca L.D., Monforte A.M., Monforte P., Rao A., Zappala M., Balzarini J., De Clercq E., Pannecouque C., and Witvrouw M. Bioorg. Med. Chem. Lett. 11 (2001) 1793
43. Kaushik-Basu N., Bopda-Waffo A., Talele T.T., Basu A., Chen Y., and Guniz Kucukguzel S. Front. Biosci. 13 (2008) 3857
44. Srivastava T., Haq W., and Katti S.B. Tetrahedron 58 (2002) 7619